Moberg Derma Raises Second Round

Moberg Derma AB, a Swedish drug company focused on skin diseases, has raised SEK 27.7 million ($4.03 million) in second-round funding. The Baltic Sea Foundation led the deal, and was joined by Iris, company management and individual angels. www.mobergderma.se